The 7th China Headquarters Economic International Summit was held, and a company in Changping was awarded the "Foreign R & D Headquarters"!

On the morning of September 3rd, the 7th China Headquarters Economic International Summit Forum hosted by the Municipal Commerce Bureau and the World Trade Website Alliance and hosted by the Beijing Headquarters Enterprise Association was held at the National Convention Center. The theme of "Innovation Driven Resources Integration Promoting the Economic Development of the Headquarters" was discussed, and it was issued to a group of "newly recognized multinational company regional headquarters" and "foreign research and development headquarters". A key enterprise in Changping District, Beijing Nuochengjianhua Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Nuocheng Jianhua"), was awarded the "Foreign R & D Headquarters".

As a high -tech enterprise based on China, which is a global biomedical high -tech company, Nuo Chengjian has strong independent innovation capabilities, builds an integrated biomedical innovation platform, and has created a strong R & D and clinical development team. At present, enterprises have built the entire biomedical industry chain from source innovation, clinical development, commercialization to production. In 2022, the company continued to cultivate innovation. Obitinini was included in the national medical insurance at the end of 2021 to benefit more patients with lymphoma.

Since its establishment 7 years, Nuocheng Jianhua has always maintained rapid development. In August this year, Nuocheng Jianhua Innovation Pharmaceutical Base started in Changping. It is the construction of major projects in Changping District in 2022. It has also been included in 100 major scientific and technological innovation in Beijing in 2022 And high -precision industrial projects will be used to build the company's headquarters building, innovative pharmaceutical research and development center, and macromolecular production bases to support the company's growing business needs, while supporting Beijing to build a world -leading "Valley".

In the next step, our district will continue to adhere to innovation -driven development, become a major pharmaceutical and health industry, implement the pharmaceutical health collaborative innovation action plan, accelerate the layout of key tracks such as biotechnology, digital+medical care, and promote the high -quality economic development of our district.

Deputy District Chief Guo Qingyao attended.

Photo/Xiang Ling Xiao

- END -